Regarding the role of MMP‐10 (matrix metalloproteinase 10) in preclinical AD, we note that previous studies found increased levels of CSF MMP‐10 in AD, as well as increased rates of disease progression in those with high CSF MMP‐10 levels at baseline (Martino Adami et al, 2022). The gene discussed is MMP10; the disease is Alzheimer disease.